Clinical Trials Directory

Trials / Completed

CompletedNCT05175664

Novel Diagnostic and Disease Stage Biomarkers in AD

TRacking Alzheimer´s Disease: a Study of Disease trajeCtory and Development of Diagnostic and Disease Stage biomarKers in AD (TRACK-AD)

Status
Completed
Phase
Study type
Observational
Enrollment
350 (actual)
Sponsor
Danish Dementia Research Centre · Network
Sex
All
Age
30 Years – 110 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the efficacy of novel biomarkers, namely blood-based biomarkers, pupillometry and actigraphy to track and predict progression of Alzheimer's disease (AD). Furthermore, the study will investigate the diagnostic value of pupillometry and actigraphy for AD.

Detailed description

This study consist of three sub-studies. In study 1, participants diagnosed with mild cognitive impairment due to AD or mild to moderate AD will be followed for up to 24 months with repeated blood samples, pupillometry, actigraphy, cognitive tests and a control brain scan. In study 2, patients under investigation of a neurodegenerative disease who have a planned lumbar puncture in the Memory clinic will be invited to this study. Participants will undergo pupillometry and blood samples two times approximately one and four weeks after the lumbar puncture. In study 3, participants with a dementia diagnosis will undergo pupillometry and actigraphy at a single visit.

Conditions

Interventions

TypeNameDescription
OTHERLong-term studyNo intervention. Investigations: cognitive tests, blood samples, pupillometry, actigraphy, and FDG-PET/MR brain scan.
OTHERShort-term studyNo intervention. Investigations: blood samples and pupillometry.
OTHERCross-sectional studyNo intervention. Investigations: cognitive tests, pupillometry and actigraphy.

Timeline

Start date
2022-01-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-01-04
Last updated
2025-05-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05175664. Inclusion in this directory is not an endorsement.